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NOTICE
This issue of MMWR Recommendations and Reports (Vol. 49, No. RR-16) is a reprint
of the Executive Summary of the Surgeon General’s report entitled Reducing Tobacco
Use, released earlier this year. The report is included in the MMWR series of publications
so that the material can be readily accessible to the public health community.
Copies of the full report (stock no. 017-023-00204-0) are available for $47 from the
Superintendent of Documents, U.S. Government Printing Office, Washington, DC 20402;
telephone (202) 512-1800.
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Message from Donna E. Shalala
Secretary of Health and Human Services
This nation is faced with many challenges in its efforts to improve the health status of
all people living in the United States. One of the biggest challenges is to remedy the fact
that approximately one-fourth of our adults continue to smoke and that tobacco use rates
among our youth have increased since the early 1990s. Tobacco use, particularly ciga-
rette smoking, remains the leading cause of preventable illness and death in this country.
Our overall success in improving the health status of the U.S. population thus depends
greatly on achieving dramatic reductions in the rate of tobacco use among both adults
and young people.
Reducing tobacco use is a key component of Healthy People 2010, the national action
plan for improving the health of all Americans for the first decade of the 21st century. No
fewer than 21 specific national health objectives related to tobacco are listed, including a
goal to more than halve the current rates of tobacco use among young people and adults.
Attaining all of the Healthy People 2010 tobacco use objectives will require significant
commitment and progress in numerous areas.
This Surgeon General’s report provides a major resource in our national efforts to
achieve the Healthy People 2010 tobacco use objectives. The research findings reviewed
indicate that many strategies and approaches have been shown to be effective in
preventing tobacco use among young people and in helping tobacco users end their
addiction. The challenge to public health professionals, health care systems, and other
partners in our national prevention effort is to implement these proven approaches.
Through the Secretary’s Initiative to Prevent Tobacco Use Among Teens and
Preteens, the Department works with federal and nonfederal efforts to reduce young
people’s demand for tobacco products. This Surgeon General’s report highlights addi-
tional strategies and approaches that this initiative can expand upon. Only by a coordi-
nated national effort will the tobacco use rates among our young people be reduced.
Each day that we delay in developing a comprehensive national response to this prob-
lem, 3,000 additional teens and preteens become regular smokers. That statistic poses
an urgent public health challenge and—given that we have at hand numerous strategies
proven to be effective—a moral imperative.
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Foreword
For more than three decades, the Surgeon General of the U.S. Public Health Service
has released reports focused on tobacco use and the health of the American people.  The
tone and content of these reports have changed over the years.  Early on, there was a
need for critical review of the epidemiologic and biologic aspects of tobacco use.  Today,
the deleterious effects are well documented, and the reports have begun to investigate
the social, economic, and cultural consequences of these effects and what can be done to
address them.  The present report assesses past and current efforts to reduce the use of
tobacco in this country and thereby ameliorate its disastrous health effects.
Tobacco use is an extraordinary phenomenon.  Although substantial progress has
been made since the initial report of the Surgeon General’s Ad Hoc Committee in 1964,
approximately a quarter of the U.S. adult population smokes, and the percentage of high
school youth who smoke has steadily increased throughout the 1990s.
Results from community-based interventions and statewide programs show that a
comprehensive approach to tobacco control is needed to curtail the epidemic.  This
report summarizes several effective approaches to reducing tobacco use and presents
the considerable evidence—as well as the attendant controversies—supporting their
application.  Multifaceted school-based education programs that are performed in con-
junction with community-based campaigns have met with substantial success.  The man-
agement of nicotine addiction in persons who already smoke has the benefit of clinical
tools, that is, systems for weaning persons from nicotine, the efficacy of which is clearly
demonstrated.  Product regulation, enforcement of clean indoor air standards, and pro-
tecting young people from the supposed attractiveness of cigarettes all promise sub-
stantial impact.  By analyzing the economics of tobacco and by examining models that
assess the effect of economic policies, we find that various approaches can mitigate the
adverse outcomes associated with tobacco use—and can do so without the dire eco-
nomic consequences claimed by those who profit from tobacco use.
But if the evidence is clear that tobacco use is harmful and if the tools are available to
reduce its use, why has the reduction in prevalence been less than would be expected?
The answer is very complex.  As described in Chapter 1 of this report, numerous forces
influence a person’s decision to smoke, or if that person is a smoker, the forces that drive
continued use.  The most important force for smoking is the totality of industry activity,
including advertising, promotion, organizational activity, support for ancillary issues, and
political action, which  maintains marketability and profitability of the product.  Efforts to
reduce tobacco use face a more than $5 billion annual budget that the tobacco industry
dedicates to advertising and promotion aimed at sustaining or increasing tobacco use.
Nonetheless, there is cause for optimism based on considerable public support for ef-
forts to prevent children from becoming addicted to tobacco.  If the recent pattern of
increases in youth tobacco use can be reversed, we can make progress toward tobacco-
free generations in the future.
Jeffrey P. Koplan, M.D., M.P.H.
Director
Centers for Disease Control and Prevention
and
Administrator
Agency for Toxic Substances and Disease Registry
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Preface
from the Surgeon General
U.S. Department of Health and Human Services
Almost 50 years ago, evidence began to accumulate that cigarette smoking poses an
enormous threat to human health.  More than 30 years ago, an initial report from the
Surgeon General’s office made an unqualified announcement of tobacco’s harm.  Begin-
ning in 1969, the series of Surgeon General’s reports began meticulous documentation of
the biologic, epidemiologic, behavioral, pharmacologic, and cultural aspects of tobacco
use.  The present report, an examination of the methods and tools available to reduce
tobacco use, is being issued at a time of considerable foment.  The past several years
have witnessed major initiatives in the legislative, regulatory, and legal arenas, with a
complex set of results still not entirely resolved.
This report shows that a variety of efforts aimed at reducing tobacco use, particularly
by children, would have a heightened impact in the absence of countervailing pressures
to smoke.  Besides providing extensive background and detail on historical, social, eco-
nomic, clinical, educational, and regulatory efforts to reduce tobacco use, the report
indicates some clear avenues for future research and implementation.  It is of special
concern to derive a greater understanding of cultural differences in response to tobacco
control measures.  Since racial and ethnic groups are differentially affected by tobacco,
elimination of disparities among these groups is a major priority.
Perhaps the most pressing need for future research is to evaluate multifocal, multi-
channel programs that bring a variety of modalities together.  For example, as Chapter 3
demonstrates, school-based education programs are more effective when coupled with
community-based initiatives that involve mass media and other techniques.  As pointed
out in Chapter 4, a combination of behavioral and pharmacologic methods improves the
success rate when managing nicotine addiction.  Synergy among economic, regulatory,
and social approaches has not been fully explored, but may offer some of the most
fruitful efforts for the future.  Chapter 7 provides the preliminary data on new statewide,
comprehensive tobacco control programs, which offer great promise as new models for
tobacco control and combine multiple intervention modalities.  Although all aspects—
social, economic, educational, and regulatory—have not been combined into a fully
comprehensive effort, it is exciting to contemplate the potential impact of such an under-
taking to eventually ensure that children are protected from the social and cultural influ-
ences that lead to tobacco addiction, that all smokers are encouraged to quit as soon as
possible, and that nonsmokers are protected from environmental tobacco smoke.
David Satcher, M.D., Ph.D.
Surgeon General and
Assistant Secretary for Health
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Executive Summary
This report of the Surgeon General on smoking and health, Reducing Tobacco Use,
appears at a time of considerable upheaval in the arena of tobacco use control and
prevention. Legal and legislative efforts to protect children from tobacco initiation and to
diminish the prevalence of smoking among adults are in a state of flux, with some impor-
tant gains and some sobering setbacks. Major changes in the public stance of the tobacco
industry have evoked a reevaluation of strategies for controlling and preventing tobacco
uptake. Enormous monetary settlements have provided the resources to fuel major new
comprehensive antitobacco efforts, but the ultimate cost and benefit of these resources
are still to be determined. Into this changing landscape, the report introduces an assess-
ment of information about the value and efficacy of the major approaches that have been
used—educational, clinical, regulatory, economic, and comprehensive—to reduce
tobacco use. The report evaluates the scientific evidence for each approach, attempts to
place the approaches in the larger context of tobacco control, and provides a vision of the
trajectory for tobacco use prevention and control based on these available tools. Thus,
although our knowledge about tobacco control remains imperfect, we know more than
enough to act now. Widespread dissemination of the approaches and methods shown to
be effective in each modality and especially in combination would substantially reduce
the number of young people who will become addicted to tobacco, increase the success
rate of young people and adults trying to quit using tobacco, decrease the level of expo-
sure of nonsmokers to environmental tobacco smoke, reduce the disparities related to
tobacco use and its health effects among different population groups, and decrease the
future health burden of tobacco-related disease and death in this country.
These achievable improvements parallel the health objectives set forth in Healthy
People 2010, the national action plan for improving the health of all people living in the
United States for the first decade of the 21st century (U.S. Department of Health and
Human Services [USDHHS] 2000a). Twenty-one specific national health objectives
related to tobacco use are listed in Healthy People 2010, including reducing the rates
among young people and adults to less than half of the current rate of use. Attaining all of
these tobacco-related objectives will almost certainly require significant national com-
mitment to the various successful approaches described in this report.
The major conclusions of this report are not formal policy recommendations. Rather,
they offer a summary of the scientific literature about what works. In short, this report is
intended to offer policymakers, public health professionals, professional and advocacy
organizations, researchers, and, most importantly, the American people guidance on
how to ensure that efforts to prevent and control tobacco use are commensurate with
the harm it causes.
MAJOR CONCLUSIONS
1. Efforts to prevent the onset or continuance of tobacco use face the pervasive,
countervailing influence of tobacco promotion by the tobacco industry, a promotion
that takes place despite overwhelming evidence of adverse health effects from
tobacco use.
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2. The available approaches to reducing tobacco use—educational, clinical, regulatory,
economic, and comprehensive—differ substantially in their techniques and in the
metric by which success can be measured. A hierarchy of effectiveness is difficult to
construct.
3. Approaches with the largest span of impact (economic, regulatory, and comprehen-
sive) are likely to have the greatest long-term, population impact. Those with a smaller
span of impact (educational and clinical) are of greater importance in helping individu-
als resist or abandon the use of tobacco.
4. Each of the modalities reviewed provides evidence of effectiveness:
• Educational strategies, conducted in conjunction with community- and media-
based activities, can postpone or prevent smoking onset in 20 to 40 percent of
adolescents.
• Pharmacologic treatment of nicotine addiction, combined with behavioral
support, will enable 20 to 25 percent of users to remain abstinent at one year
posttreatment. Even less intense measures, such as physicians advising their
patients to quit smoking, can produce cessation proportions of 5 to 10 percent.
• Regulation of advertising and promotion, particularly that directed at young
people, is very likely to reduce both prevalence and uptake of smoking.
• Clean air regulations and restriction of minors’ access to tobacco products
contribute to a changing social norm with regard to smoking and may influence
prevalence directly.
• An optimal level of excise taxation on tobacco products will reduce the
prevalence of smoking, the consumption of tobacco, and the long-term health
consequences of tobacco use.
5. The impact of these various efforts, as measured with a variety of techniques, is likely
to be underestimated because of the synergistic effect of these modalities. The poten-
tial for combined effects underscores the need for comprehensive approaches.
6. State tobacco control programs, funded by excise taxes on tobacco products and
settlements with the tobacco industry, have produced early, encouraging evidence of
the efficacy of the comprehensive approach to reducing tobacco use.
CHAPTER CONCLUSIONS
Following are the specific conclusions for each chapter of the report. Note that Chap-
ters 1 and 8 have no conclusions.
Chapter 2.  Historical Review
1. In the years preceding the development of the modern cigarette, and for some time
thereafter, antismoking activity was largely motivated by moralistic and hygienic
concerns. Health concerns played a lesser role.
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2. In contrast, in the second half of the 20th century, the impetus for reducing tobacco
use was largely medical and social. The resulting platform has been a more secure
one for efforts to reduce smoking.
3. Despite the growing scientific evidence for adverse health effects, smoking norms
and habits have yielded slowly and incompletely. The reasons are complex but attrib-
utable in part to the industry’s continuing stimulus to consumption.
Chapter 3.  Educational Strategies
1. Educational strategies, conducted in conjunction with community- and media-based
activities, can postpone or prevent smoking onset in 20 to 40 percent of adolescents.
2. Although most U.S. schools have tobacco use prevention policies and programs in
place, current practice is not optimal.
3. More consistent implementation of effective educational strategies to prevent
tobacco use will require continuing efforts to build strong, multiyear prevention units
into school health education curricula and expanded efforts to make use of the influ-
ence of parents, the mass media, and other community resources.
Chapter 4.  Management of Nicotine Addiction
1. Tobacco dependence is best viewed as a chronic disease with remission and relapse.
Even though both minimal and intensive interventions increase smoking cessation,
most people who quit smoking with the aid of such interventions will eventually
relapse and may require repeated attempts before achieving long-term abstinence.
Moreover, there is little understanding of how such treatments produce their thera-
peutic effects.
2. There is mixed evidence that self-help manuals are an efficacious aid to smoking
cessation. Because these materials can be widely distributed, such strategies may
have a significant public health impact and warrant further investigation.
3. Programs using advice and counseling—whether minimal or more intensive—have
helped a substantial proportion of people quit smoking.
4. The success of counseling and advice increases with the intensity of the program and
may be improved by increasing the frequency and duration of contact.
5. The evidence is strong and consistent that pharmacologic treatments for smoking
cessation (nicotine replacement therapies and bupropion, in particular) can help
people quit smoking. Clonidine and nortriptylene may have some utility as second-
line treatments for smoking cessation, although they have not been approved by the
Food and Drug Administration (FDA) for this indication.
Chapter 5.  Regulatory Efforts
Advertising and Promotion
1. Since 1964, numerous attempts to regulate advertising and promotion of tobacco
products have had only modest success in restricting such activity.
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2. Current regulation in the United States is considerably less restrictive than that in
several other countries, notably Canada and New Zealand.
3. Current case law supports the contention that advertising does not receive the
protections of free speech under the First Amendment to the Constitution that non-
commercial speech does.
Product Regulation
1. Warning labels on cigarette packages in the United States are weaker and less con-
spicuous than those of other countries.
2. Smokers receive very little information regarding chemical constituents when they
purchase a tobacco product. Without information about toxic constituents in tobacco
smoke, the use of terms such as “light” and “ultra light” on packaging and in adver-
tising may be misleading to smokers.
3. Because cigarettes with low tar and nicotine contents are not substantially less haz-
ardous than higher-yield brands, consumers may be misled by the implied promise of
reduced toxicity underlying the marketing of such brands.
4. Additives to tobacco products are of uncertain safety when used in tobacco. Knowl-
edge about the impact of additives is negligible and will remain so as long as brand-
specific information on the identity and quantity of additives is unavailable.
5. Regulation of tobacco product sale and promotion is required to protect young people
from influences to take up smoking.
Clean Indoor Air Regulation
1. Although population-based data show declining environmental tobacco smoke (ETS)
exposure in the workplace over time, ETS exposure remains a common public health
hazard that is entirely preventable.
2. Most state and local laws for clean indoor air reduce but do not eliminate nonsmokers’
exposure to ETS; smoking bans are the most effective method for reducing ETS
exposure.
3. Beyond eliminating ETS exposure among nonsmokers, smoking bans have additional
benefits, including reduced smoking intensity and potential cost savings to employ-
ers. Optimal protection of nonsmokers and smokers requires a smoke-free environ-
ment.
Minors’ Access to Tobacco
1. Measures that have had some success in reducing minors’ access include restricting
distribution, regulating the mechanisms of sale, enforcing minimum age laws, and
providing merchant education and training. Requiring licensure of tobacco retailers
provides both a funding source for enforcement and an incentive to obey the law
when revocation of the license is a provision of the law.
2. The effect of reducing minors’ access to tobacco products on smoking prevalence
requires further evaluation.
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Litigation Approaches
1. Two historic waves of tobacco litigation were initiated by private citizens, were based
largely on theories of negligence and implied warranty, and were unsuccessful.
2. A third wave has brought in new types of claimants, making statutory as well as
common-law claims and using more efficient judicial procedures. Although several
cases have been settled for substantial money and have yielded public health provi-
sions, many other cases remain unresolved.
3. Private law initiative is a diffuse, uncentralized activity, and the sum of such efforts is
unlikely to produce optimal results for a larger policy to reduce tobacco use. On the
other hand, the actions of individuals are likely to be a valuable component in some
larger context of strategies to make tobacco use less prevalent.
Chapter 6.  Economic Approaches
1. The price of tobacco has an important influence on the demand for tobacco products,
particularly among young people.
2. Substantial increases in the excise taxes on cigarettes would have considerable im-
pact on the prevalence of smoking and, in the long-term, reduce the adverse health
effects caused by tobacco.
3. Policies that influence the supply of tobacco, particularly those that regulate inter-
national commerce, can have important effects on tobacco use.
4. Although employment in the tobacco sector is substantial, the importance of tobacco
to the U.S. economy has been overstated. Judicious policies can be joined to higher
tobacco taxes and stronger prevention policies to ease economic diversification in
tobacco-producing areas.
Chapter 7.  Comprehensive Programs
1. The large-scale interventions conducted in community trials have not demonstrated a
conclusive impact on preventing and reducing tobacco use.
2. Statewide programs have emerged as the new laboratory for developing and evalu-
ating comprehensive plans to reduce tobacco use.
3. Initial results from the statewide tobacco control programs are favorable, especially
regarding declines in per capita consumption of tobacco products.
4. Results of statewide tobacco control programs suggest that youth behaviors regard-
ing tobacco use are more difficult to change than adult ones, but initial results of these
programs are generally favorable.
BACKGROUND
What works?
It would be a boon if the answer were as easy to state as the question. Programs to
reduce the use of tobacco have a long history in the United States and in other countries,
and the accumulated experience has provided considerable empirical understanding of
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the prospects and pitfalls of such efforts. Rigorous answers to formal evaluation ques-
tions are difficult to obtain, however, in part because of the wide variety of influences that
are brought to bear on the use of tobacco. Researchers have little control over many of
these influences and are only beginning to learn how to measure some of them.
Nonetheless, a substantial body of literature exists on attempts to reduce the use of
tobacco. This report provides an overview of the major modalities that have been stud-
ied and used intensively, and it attempts, where possible, to differentiate their techniques
and outcomes. The report also attempts a more difficult task: to provide some qualitative
observations about how these efforts interact. The report is thus a prologue to the devel-
opment of a coherent, long-term policy that would permit these modalities to be used as
effectively as possible.
This report of the Surgeon General was prepared by the Office on Smoking and
Health, National Center for Chronic Disease Prevention and Health Promotion, Centers
for Disease Control and Prevention (CDC), U.S. Department of Health and Human Ser-
vices, to report current information on the health effects of cigarette smoking and smoke-
less tobacco use. Previous reports have dealt with some of the issues included in this
report, but a composite assessment of efforts to reduce tobacco use is a new topic for this
series. However, the current report must acknowledge the considerable contributions of
two prior monographs: Growing Up Tobacco Free, a report of the Institute of Medicine
(Lynch and Bonnie 1994), and Healthy People 2000: National Health Promotion and
Disease Prevention Objectives, an ongoing work of the Office of Health Promotion and
Disease Prevention (USDHHS 1991).
Several concerns guided preparation of the report. First, it was clear that the primary
countervailing influence against reducing tobacco use is the effort of the tobacco indus-
try to promote the use of tobacco products. Although this report was not conceived as a
documentation of such industry efforts, repeated reference to them is necessary to
underscore the difficulties both in achieving desired outcomes and in evaluating the
effectiveness of efforts to reduce the use of the industry’s products. Second, the report
has attempted to present the wide variety of techniques and methods used for tobacco
control, but the disparate methods make comparisons difficult. The result is more a menu
than a cookbook—a set of activities, as outlined in Chapter 7, whose combination de-
pends on specific circumstances and the context in which they are undertaken. Third, a
result of this methodological diversity is that rigorous evaluation of the ways in which
tobacco reduction efforts interact remains part of the unfinished research agenda. Al-
though interaction of interventive efforts is noted several places in the report (see, for
example, the discussion of the interaction of school education with community-based
programs in Chapter 3), such demonstration of synergy has been elusive.
Finally, during the report’s preparation, a cascade of legal and legislative events
substantially changed the landscape where the diverse efforts to reduce tobacco use
take place. Several legal rulings, still under adjudication, and the Master Settlement
Agreement between states and the tobacco industry to recover costs of government
programs have altered prospects for reducing tobacco use through large-scale social
maneuvers. Many of these issues are still unresolved, and they are likely to influence
activities in the coming years.
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ISSUES IN REDUCING TOBACCO USE
Two themes have permeated the history of tobacco use in the United States. First,
and most obviously, tobacco is an extraordinary economic fuel, and its powerful eco-
nomic impact comes into direct conflict with its vast social costs. Second, antitobacco
activity has a continuous history characterized by waxing and waning and by a changing
mix of motivations and strategies. These two themes are inextricably linked, and their
interaction provides a backdrop for current efforts to reduce tobacco use.
Such efforts take place in a complicated context. Chronic diseases have largely re-
placed infectious processes as the leading causes of death during the 20th century
(Rothenberg and Koplan 1990). But this replacement has occurred during a period of
remarkable gains in life expectancy. Mortality is now less than half of what it was in 1900.
The single most important risk associated with the leading chronic diseases is cigarette
smoking; the evidence for that statement fills volumes of Surgeon General’s reports on
smoking and health, and these volumes are merely summaries of a massive literature.
Since the first of these reports in 1964, the prevalence of smoking has declined by nearly
half, and it is clear that the declining use of tobacco has contributed to the observed
decline in mortality. But the decline has been a slower decline than would be warranted
by awareness of the well-publicized public health threat that smoking poses. The forces
that have tried to accelerate the decline may be thought of collectively as “interven-
tions,” although the term, in a more narrow sense, is often reserved for circumscribed,
planned, and measurable activities. Many of the maneuvers described in this report do
not meet the narrower definition, but all share the common characteristic of being di-
rected toward a reduction in tobacco use.
The result is a considerable challenge for evaluation. In an environment in which
multiple interventions are in play, the ability to attribute an individual positive outcome
(e.g., smoking cessation, prevention of smoking uptake) to one of them is virtually impos-
sible. Although the epidemiologic methods exist to evaluate attribution in the aggregate,
data are rarely available to make such judgments. The challenge of evaluating these
separate efforts and strategies results from their disparate nature and the type of metric
that may be appropriate to their evaluation.
Management of nicotine addiction (Chapter 4), for example, is usually studied by
using standard epidemiologic study design—often a prospective comparison of a study
group and a control group—and the effect is measured by some form of the relative or
attributable risk statistic. Educational strategies (Chapter 3), like other behavioral stud-
ies, may use similar statistics but usually invoke a different set of confounding factors to
be considered; sorting out the relative influence of such factors often requires complex
multi-variate procedures. Regulatory efforts (Chapter 5) are frequently evaluated after
the effect (with a pre- and post-type of study design) or are evaluated according to
ecological correlations with changes in epidemiologic trends. Economic measures (Chap-
ter 6) depend for their evaluation on econometric information—that is, on administrative
data sets and survey results that are subjected to correlation and trend analysis. Finally,
comprehensive program strategies are often evaluated using surveillance data sys-
tems, trend analyses, and case studies.
In each instance, some form of evaluation is possible, but the ability to connect the
intervention to the outcome differs greatly among these efforts, as does the ability to
estimate impact. Theoretically, it might be possible to associate each effort with some
presumed number of persons who start smoking or some number who quit, but to do so
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would usually require numerous assertions and assumptions. Without a common metric,
the various types of efforts to reduce tobacco use are difficult to compare quantitatively,
and perhaps a more qualitative approach should be used. One approach would be to
consider the potential span of impact (the proportion of the population, or population
sectors) that the particular effort can exercise in the context of a qualitative estimate of
its potential impact. For example, clinical methods to manage nicotine addiction may
now be thought to have relatively high impact, but a relative small span. Economic
measures can be judged to have both high impact and large span. Each of the interven-
tions has its appropriate place and context: they line up side by side and not in relative
order. Their use is predicated on the particular context in which they are to operate.
Because they all face the same counterinfluence of the industry’s tobacco promotion, a
reasonable case can be made that the large-scale strategies (economic and regulatory)
have the greatest direct impact on that barrier. But the context necessary for those large-
scale efforts to work depends on public attitudes and social norms that must be influ-
enced by other means.
In the 1990s, it became increasingly apparent that a public health success in reducing
tobacco use requires activity on all fronts. A comprehensive approach—one that opti-
mizes synergy from a mix of strategies—has emerged as the guiding principle for future
efforts to reduce tobacco use. Such an approach makes moot the issue of a hierarchy of
interventions, since a comprehensive approach presupposes an interdependence of the
available strategies. A coordinated, cohesive infrastructure makes intuitive sense, since
it permits a modular approach to the interventions themselves, but has been challenged
on analytic grounds. In such a framework, attribution of success to particular program
elements is difficult, and there is no experimental evidence (nor is there likely to be) that
an approach that is comprehensive is superior to one that is not. Nonetheless, the 20th
century’s difficult experience with tobacco control (as described in Chapter 2) and the
previous decade’s success in changing social norms and generating assets (as discussed
in Chapter 7) lend empirical credibility to the comprehensive approach.
Finally, a separate theme—not a major focus of the current report because two other
recent, important publications have emphasized this issue—is the elimination of health
disparities related to tobacco use, which poses a great challenge to this nation. The 1998
Surgeon General’s report, Tobacco Use Among U.S. Racial/Ethnic Minority Groups
(USDHHS 1998), was the first to address the diverse tobacco control needs of the four
major U.S. racial/ethnic minority groups—African Americans, American Indians and
Alaska Natives, Asian Americans and Pacific Islanders, and Hispanics. Healthy People
2010 has two overarching goals: increase quality and years of healthy life and eliminate
health disparities among different segments of the U.S. population. Evidence reviewed in
these two publications highlights the significant disparities in health that exist in the
United States. These publications also highlight the critical need for a greater focus on
this issue, both in research and in public health action.
FINDINGS
Each of the approaches described in this report shows evidence of effectiveness. In
some instances, the synergism that might be expected through interaction among these
various efforts has been documented, and the implications for future tobacco control and
prevention activities are noted.
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Historical Review (Chapter 2)
The forces that have shaped the movement to reduce tobacco use over the past 100
years are complex and intertwined. In the early years (1880–1920), antitobacco activ-
ity—some of it quite successful—was motivated by moral and hygienic principles. After
important medical and epidemiologic observations of the midcentury linked smoking to
lung cancer and other diseases, and after the subsequent appearance of the 1964 report
of the advisory committee to the Surgeon General on smoking and health (U.S. Depart-
ment of Health, Education, and Welfare 1964), the movement to reduce tobacco use was
fueled by knowledge of the health risks that tobacco use poses and by reaction against
the continued promotion of tobacco in the face of such known risks. Despite overwhelm-
ing evidence of adverse health consequences of smoking, the stubborn norm of smoking
in the United States has receded slowly, in part because of such continued promotion that
works synergistically with tobacco addiction. Although strategies have varied, health
advocates have focused in recent years on the prevention of harm to nonsmokers and on
the concept of smoking as a pediatric disease, with the consequent need for protecting
young persons from forces influencing them to smoke.
Educational Strategies (Chapter 3)
The design of educational programs for tobacco use prevention and the methods
used to evaluate them have become increasingly refined over the past two decades.
Early studies tended to be confined to the school context, to have short duration, and to
be of low intensity. Studies tended to focus on a single modality and to ignore the larger
context in which prevention takes place. The reported size, scope, and duration of pro-
gram effects have become larger in recent reports. In particular, several large programs
have attempted a multifaceted approach that incorporates other than school-based
modalities. Improvements in evaluation designs have increased confidence in the valid-
ity of these reports. The pattern of consistency across this group of large studies also
provides assurance that these effects can be achieved in a variety of circumstances
when programs include the critical multiple elements that have been defined by this
research literature.
To summarize the major findings, school-based social influences programs have sig-
nificant and substantial short-term impacts on smoking behavior. Those programs with
more frequent educational contacts during the critical years for smoking adoption are
more likely to be effective, as are programs that address a broad range of educational
needs. These effects have been demonstrated in a range of implementation models and
student populations. The smoking prevention effects of strong school programs can be
extended through the end of high school or longer when combined with relatively inten-
sive efforts directed through other powerful channels, such as strategies that vigorously
engage the influences of parents, the mass media, and other community resources.
These conclusions have been codified in national guidelines for school programs to pre-
vent tobacco use.
Thus, an extensive body of research findings document the most effective educa-
tional programs for preventing tobacco use. This research has produced a wide array of
curricula, protocols, and recommendations that have been codified into national guide-
lines for schools. Implementing guidelines could postpone or prevent smoking onset in 20
to 40 percent of U.S. adolescents. Unfortunately, existing data suggest that evidence-
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based curricula and national guidelines have not been widely adopted. By one set of
criteria, less than 5 percent of schools nationwide are implementing the major compo-
nents of CDC’s Guidelines for School Health Programs to Prevent Tobacco Use and Ad-
diction (CDC 1994). Almost two-thirds of schools (62.8 percent) had smoke-free building
policies in 1994, but significantly fewer (36.5 percent) reported such policies that included
the entire school environment.
Schools, however, should not bear the sole responsibility for implementing educa-
tional strategies to prevent tobacco use. Research findings, as noted, indicate that school-
based programs are more effective when combined with mass media programs and
with community-based efforts involving parents and other  community resources. In
addition, CDC’s school health guidelines and numerous Healthy People 2010  objectives
recognize the critical role of implementing tobacco-free policies involving faculty, staff,
and students and relating to all school facilities, property, vehicles, and events. Although
significant progress is still required, the current evaluation base provides clear direction
for the amalgamation of school-based programs with other modalities for reducing to-
bacco use.
Management of Nicotine Addiction (Chapter 4)
The management of nicotine addiction is a complex field that continues to broaden its
understanding of the determinants of smoking cessation. Current literature suggests
that several modalities are effective in helping smokers quit. Although the overall effect
of such intervention is modest if measured by each attempt to quit, the process of over-
coming addiction is a cyclic one, and many who wish to quit are eventually able to do so.
The available approaches to management of addiction differ in their results.
Self-Help Manuals and Minimal Clinical Interventions
Although self-help manuals have had only modest and inconsistent success at help-
ing smokers quit, manuals can be easily distributed to the vast population of smokers
who try to quit on their own each year. Adjuvant behavioral interventions, particularly
proactive telephone counseling, may significantly increase the effect of self-help materi-
als. Process measures are not routinely incorporated into self-help investigations, but
the available process data suggest that persons who not only have a self-help manual
but also perform the exercises recommended in the manual are more likely to quit
smoking than are persons who try to quit smoking without them.
Substantial evidence suggests that minimal clinical interventions (e.g., a health care
provider’s repeated advice to quit) foster smoking cessation and that the more multifac-
torial or intensive interventions produce the best outcomes. These findings highlight the
importance of cessation assistance from clinicians, who have access to more than 70
percent of smokers each year. Moreover, minimal clinical interventions have been found
to be effective in increasing smokers’ motivation to quit and are cost-effective (see
“Cost-Effectiveness” in Chapter 4). However, research has not fully clarified the specific
elements of minimal interventions that are most important to clinical success or the
specific changes they produce in smokers that lead to abstinence.
Intensive Clinical Interventions
Intensive programs—more formally, systematic services to help people quit smok-
ing—serve an important function in the nation’s efforts to reduce smoking, despite the
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resources the programs demand and the relatively small population of smokers who use
them. Such programs may be particularly useful in treating those smokers who find it
most difficult to quit. Because intensive smoking cessation programs differ in structure
and content, evaluation is often hampered by variation in methodology and by a lack of
research addressing specific treatment techniques. Because few studies have chosen to
isolate single treatments, assessment of the effectiveness of specific approaches is diffi-
cult. Nonetheless, skills training, rapid smoking, and both intratreatment and
extratreatment social support have all been associated with successful smoking cessa-
tion. When such treatments are shown to be effective, they are usually part of a multifac-
torial intervention. Little clear evidence has implicated particular psychological,
behavioral, or cognitive mechanisms as the agents of change. The specific impact of
intensive interventions may be masked by the efficacy of several multicomponent pro-
grams, some of which have achieved cessation proportions of 30 to 50 percent. Thus, in
their positive effect on smoking cessation and long-term abstinence rates, intensive
interventions seem little different from other forms of counseling or psychotherapy. With
intensive interventions, as with counseling, it is difficult to attribute the efficacy to specific
characteristics of the interventions or to specific change mechanisms.
Pharmacologic Interventions
Abundant evidence confirms that nicotine gum and the nicotine patch are effective
aids to smoking cessation. The efficacy of nicotine gum may depend on the amount of
behavioral counseling with which it is paired. The 4-mg dose (rather than the 2-mg dose)
may be the better pharmacologic treatment for heavy smokers or for those highly
dependent on nicotine. The nicotine patch appears to exert an effect independent of
behavioral support, but absolute abstinence rates increase as more counseling is added
to patch therapy. Nicotine inhalers and nicotine nasal spray are effective aids for smok-
ing cessation, although their mechanisms of action are not entirely clear. All nicotine
replacement therapies produce side effects, but these are rarely so severe that patients
must discontinue use. Nicotine nasal spray appears to have greater potential for
inappropriate use than other nicotine replacement therapies. Nicotine replacement thera-
pies, especially the gum and the patch, have been shown to delay but not prevent weight
gain following smoking cessation. All nicotine replacement therapies are thought to work
in part by reducing withdrawal severity. The available evidence suggests that they do
ameliorate some elements of withdrawal, but the relationship between withdrawal sup-
pression and clinical outcome is inconsistent.
Bupropion is the first nonnicotine pharmacotherapy for smoking cessation to be stud-
ied in large-scale clinical trials. Results suggest that bupropion is an effective aid to
smoking cessation. In addition, bupropion has been demonstrated to be safe when used
jointly with nicotine replacement therapy. In the only direct comparison with a nicotine
replacement product, bupropion achieved quit rates about double those achieved with
the nicotine patch. Bupropion appears to delay but not prevent postcessation weight
gain. The available literature contains inconsistent evidence regarding bupropion-
mediated withdrawal relief. Bupropion does not appear to work by reducing postcessation
symptoms of depression, but its mechanism of action in smoking cessation remains
unknown.
Evidence has suggested that clonidine is capable of improving smoking cessation
rates. Clonidine is hypothesized to work by alleviating withdrawal symptoms. Although
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clonidine may reduce craving for cigarettes after cessation, it does not consistently
ameliorate other withdrawal symptoms, and its effects with weight gain are unknown.
Unpleasant side effects are common with clonidine use.
Antidepressants and anxiolytics are potentially useful agents for smoking cessation.
At present only nortriptylene appears to have consistent empirical evidence of smoking
cessation efficacy. However, tricyclic antidepressants produce a number of side effects,
including sedation and various anticholinergic effects, such as dry mouth.
In summary, research on methods to treat nicotine addiction has documented the
efficacy of a wide array of strategies. The broad implementation of these effective treat-
ment methods could produce a more rapid and probably larger short-term impact on
tobacco-related health statistics than any other component of a comprehensive tobacco
control effort. It has been estimated that smoking cessation is more cost-effective than
other commonly provided clinical preventive services, including Pap tests, mammogra-
phy, colon cancer screening, treatment of mild to moderate hypertension, and treatment
of high levels of serum cholesterol.
Contemporaneously with the appearance of this report, research advances in man-
aging nicotine addiction have been summarized in evidence-based clinical practice guide-
lines by the Centers for Disease Control and Prevention (CDC). That document confirms
that less intensive interventions, such as brief physician advice to quit smoking, could
produce cessation rates of 5 to 10 percent per year. More intensive interventions, com-
bining behavioral counseling and pharmacologic treatment of nicotine addiction, can
produce 20 to 25 percent quit rates at one year. Thus, the universal provision of even less
intensive interventions to smokers at all clinical encounters could each year help millions
of U.S. smokers quit (Fiore et al. 2000).
Progress has been made in recent years in disseminating clinical practice guidelines
on smoking cessation. Healthy People 2010  Objective 27-8 calls for universal insurance
coverage of evidence-based treatment for nicotine dependency by both public and pri-
vate payers. Similarly, CDC’s Best Practices for Comprehensive Tobacco Control Pro-
grams  advises states that tobacco-use treatment initiatives should include
• Establishing population-based counseling and treatment programs, such as
cessation help lines.
• Making the system changes recommended by the CDC-sponsored cessation
guidelines.
• Covering treatment for tobacco use under both public and private insurance.
• Eliminating cost barriers to treatment for under-served populations, particularly
the uninsured (CDC 1999, p. 24).
Regulatory Efforts (Chapter 5)
Advertising and Promotion
Attempts to regulate advertising and promotion of tobacco products were initiated in
the United States almost immediately after the appearance of the 1964 report to the
Surgeon General on the health consequences of smoking (USDHEW 1964). Underlying
these attempts is the hypothesis that advertising and promotion recruit new smokers
and retain current ones, thereby perpetuating a great risk to public health. The tobacco
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industry asserts that the purpose of marketing is to maintain brand loyalty. Considerable
evidence has accumulated showing that advertising and promotion are perhaps the
main motivators for adopting and maintaining tobacco use. Attempts to regulate tobacco
marketing continue to take place in a markedly adversarial and litigious atmosphere.
The initial regulatory action, promulgated in 1965, provided for a general health warn-
ing on cigarette packages but effectively preempted any further federal, state, or local
requirements for health messages. In 1969, a successful court action invoked the Fair-
ness Doctrine (not previously applied to advertising) to require broadcast media to air
antitobacco advertising to counter the paid tobacco advertising then running on televi-
sion and radio. Indirect evidence suggests that such counteradvertising had consider-
able impact on the public’s perception of smoking. Not surprisingly, the tobacco industry
supported new legislation (adopted in 1971) prohibiting the advertising of tobacco prod-
ucts on broadcast media, because such legislation also removed the no-cost broad-
casting of antitobacco advertising. A decade later, a Federal Trade Commission (FTC)
staff report asserted that the dominant themes of remaining (nonbroadcast) cigarette
advertising associated smoking with “youthful vigor, good health, good looks and per-
sonal, social and professional acceptance and success” (Myers et al. 1981, p. 2-13). A
nonpublic version of the report detailed some of the alleged marketing strategy
employed by the industry; the industry denied the allegation that the source material for
the report represented industry policy. Nonetheless, some of these concerns led to the
enactment of the Comprehensive Smoking Education Act of 1984 (Public Law 98-474),
which required a set of four rotating warnings on cigarette packages. The law did not,
however, adopt other FTC recommendations that product packages should bear infor-
mation about associated risks of addiction and miscarriage, as well as information on
toxic components of cigarettes. In fact, many FTC-recommended requirements for pack-
aging information that have been enacted in other industrialized nations have not been
enacted in the United States.
The role of advertising is perhaps best epitomized by R.J. Reynolds Tobacco Company’s
Camel brand campaign (initiated in 1988) using the cartoon character “Joe Camel.”
Considerable research has demonstrated the appeal of this character to young people
and the influence that the advertising campaign has had on minors’ understanding of
tobacco use and on their decision to smoke. In 1997, the FTC brought a complaint assert-
ing that by inducing minors to smoke, R.J. Reynolds’ advertising practices violated the
Federal Trade Commission Act (Public Law 96-252). The tobacco company subsequently
agreed to cease using the Joe Camel campaign. Although the FTC’s act grants no private
right of enforcement, a private lawsuit in California resulted in a settlement whereby the
tobacco company agreed to cease its Joe Camel campaign; notably, the Supreme Court
of California rejected R.J. Reynolds’ argument that the Comprehensive Smoking Educa-
tion Act of 1984 preempted the suit’s attempt to further regulate tobacco advertising.
Product Regulation
Current tobacco product regulation requires that cigarette advertising disclose levels
of “tar” (an all-purpose term for particulate-phase constituents of tobacco smoke, many
of which are carcinogenic or otherwise toxic) and nicotine (the psychoactive drug in
tobacco products that causes addiction) in the smoke of manufactured cigarettes and
that warning labels appear on packages and on some (but not all) advertising for manu-
factured cigarettes and smokeless tobacco. The current federal laws preempt, in part,
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states and localities from imposing other labeling regulations on cigarettes and smoke-
less tobacco. Federal law (the Comprehensive Smokeless Tobacco Health Education Act
of 1986 and the Comprehensive Smoking Education Act of 1984) requires cigarette and
smokeless tobacco product manufacturers to submit a list of additives to the Secretary of
Health and Human Services; attorneys for the manufacturers released such lists in 1994
to the general public. Smokeless tobacco manufacturers are required to report the total
nicotine content of their products, but these data may not be released to the public.
Tobacco products are explicitly protected from regulation in various federal consumer
safety laws. No federal public health laws or regulations apply to cigars, pipe tobaccos, or
fine-cut cigarette tobaccos (for “roll-your-own” cigarettes).
Although much effort has been devoted to considering the need for regulating nico-
tine delivery, tar content, and the use of additives, until recently no regulation had directly
broached the issue of whether tobacco should be subject to federal regulation as an
addictive product. Responding in part to several petitions filed by the Coalition on Smok-
ing OR Health in 1988 and 1992, the FDA began serious consideration of the need for
product regulation. Motivated by the notion that the cigarette is a nicotine delivery sys-
tem, by allegations of product manipulation of nicotine levels, and by the concept that
smoking is a pediatric disease and that young people are especially susceptible to ciga-
rette advertising and promotion, in August 1995 the FDA issued in the Federal Register
(1) a proposed rule of regulations restricting the sale and distribution of cigarettes and
smokeless tobacco products to protect children and adolescents and (2) an analysis of
the FDA’s jurisdiction over cigarettes and smokeless tobacco. The final regulations pub-
lished by the FDA on August 28, 1996, differed only slightly from the proposed regula-
tion. The announcement prompted immediate legal action on the part of the tobacco
industry, advertising interests, and the convenience store industry, which challenged the
FDA’s jurisdiction over tobacco products. In April 1997, a federal district court upheld the
FDA’s jurisdiction over tobacco products, but held that it lacked authority under the statu-
tory provision relied on to regulate tobacco product advertising.
Although many of the FDA’s regulations on tobacco sales and distribution were incor-
porated, to some extent, in the June 20, 1997, proposed settlement of lawsuits between
41 state attorneys general and the tobacco industry, the settlement presupposed con-
gressional legislation that would uphold the FDA’s asserted jurisdiction. After consider-
able congressional negotiation, no such legislation emerged. In August 1998, a three-judge
panel of the United States Court of Appeals for the Fourth Circuit held that the FDA lacked
jurisdiction to regulate tobacco products. In November 1998, the full court of appeals
rejected the government’s request for rehearing by the entire court. On March 21, 2000,
in a 5 to 4 decision, the United States Supreme Court affirmed the decision of the United
States Court of Appeals for the Fourth Circuit and held that the FDA lacks jurisdiction
under the Federal Food, Drug, and Cosmetic Act to regulate tobacco products as custom-
arily marketed. As a result of this decision, the FDA’s August 1996 assertion of jurisdiction
over cigarettes and smokeless tobacco and regulations restricting the sale and distribu-
tion of cigarettes and smokeless tobacco to protect children and adolescents (principally
codified at 21 Code of Federal Regulations Part 897) are invalid.
Clean Indoor Air Regulation
Unlike the regulation of tobacco products per se and of their advertising and promo-
tion, regulation of exposure to ETS has encountered less resistance. This course is prob-
ably the result of (1) long-standing grassroots efforts to diminish exposure to ambient
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tobacco smoke and (2) consistent epidemiologic evidence of adverse health effects of
ETS. Since 1971, a series of rules, regulations, and laws have created smoke-free envi-
ronments in an increasing number of settings: government offices, public places, eating
establishments, worksites, military establishments, and domestic airline flights. As of
December 31, 1999, smoking was restricted in public places in 45 states and the District
of Columbia. Currently, some 820 local ordinances, encompassing a variety of enforce-
ment mechanisms, are in place.
The effectiveness of clean indoor air restrictions is under intensive study. Most stud-
ies have concluded that even among smokers, support for smoking restrictions and
smoke-free environments is high. Research has also verified that the institution of smoke-
free workplaces effectively reduces nonsmokers’ exposure to ETS. Although smoke-free
environments have not reduced smoking prevalence in most studies, such environments
have been shown to decrease daily tobacco consumption among smokers and to in-
crease smoking cessation.
Minors’ Access to Tobacco
There is widespread approval for restricting the access of minors to tobacco prod-
ucts. Recent research, however, has demonstrated that a substantial proportion of teen-
agers who smoke purchase their own tobacco, and the proportion varies with age, social
class, amount smoked, and factors related to local availability. In addition, research has
shown that most minors can easily purchase tobacco from a variety of retail outlets. It
has been suggested that a reduction in commercial availability may result in a reduced
prevalence of tobacco use among minors.
Several approaches have been taken to limiting minors’ access to tobacco. All states
prohibit sale or distribution of tobacco to minors. More than two-thirds of states regulate
the means of sale through restrictions on minors’ use of vending machines, but many of
these restrictions are weak, and only two states have total bans on vending machines.
Restrictions on vending machines are a subclass of the larger category of regulation of
self-service cigarette sales; in general, such regulation requires that cigarettes be
obtained from a salesperson and not be directly accessible to customers. Such policies
can reduce shoplifting as well, an important source of cigarettes for some minors.
Regulations directed at the seller include the specification of a minimum age for sale
(18, in all but two states and Puerto Rico), a minimum age for the seller, and the prominent
in-store announcement of such policy. Providing merchant education and training is an
important component of comprehensive minors’ access programs. Penalties for sales to
minors vary considerably; in general, civil penalties have been found to be more effec-
tive than criminal ones. Requiring licensure of tobacco retailers has been found to pro-
vide a funding source for compliance checks and to serve as an incentive to obey the law
when revocation of the license is a provision of the law. Applying penalties to business
owners, instead of to clerks only, is considered essential to preventing sales to minors.
Tobacco retail outlets and the tobacco industry have vigorously opposed this policy. An
increasing number of states and local jurisdictions are imposing sanctions against
minors who purchase, possess, or use tobacco products. Sanctions against both buyers
and sellers are enforced by a variety of agencies and mechanisms. Because regulations
in general may be more effective if generated and enforced at the local level, consider-
able energy is devoted to the issue of opposing or repealing preemption of local authority
by states. Public health analyses have resulted in strong recommendations that state
laws not preempt local action to curb minors’ access to tobacco.
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Litigation Approaches
Private litigation shifts enforcement of public health remedies from the enterprise or
the government to the private individual—typically, victims or their surrogates. In the tort
system, the coalescence of instances in which injurers are forced to compensate the
injured can create a force that generates preventive effects. Though relatively inefficient
as a system for compensating specific classes of injuries, the tort system is justified by its
generation of preventive actions and by its flexibility. Tobacco represents an atypical
pattern of litigation and product modification, because private law remedies have not yet
succeeded in institutionalizing recovery for tobacco injuries or have not yet generated
significant preventive effects. In the case of tobacco, regulation has been the predomi-
nant control, and such regulation has been distinctive in relying primarily on notification
requirements rather than safety requirements.
Private litigation against tobacco has occurred in several distinct waves. The first
wave was launched in 1954 and typically used one or both of two legal theories: negli-
gence and implied warranty. Courts proved unreceptive to both these arguments, and
this approach had receded by the mid-1970s. In many of these and subsequent cases,
legal devices and exhaustion of plaintiff resources figured prominently in the defen-
dants’ strategy. A second wave began in 1983 and ended in 1992. In these cases, the
legal theory shifted from warranty to strict liability. The tobacco industry based its
defense on smokers’ awareness of risks and so-called freedom of choice. For example,
plaintiffs argued that the addictive nature of nicotine limited free choice; defense counsel
rebutted by pointing to the large number of former smokers who successfully quit. Taking
freedom-of-choice defense even further, counsel argued that the claimant’s lifestyle was
overly risky by choice or was in some way immoral. The case that symbolized the sec-
ond-wave litigation was that filed by Rose Cipollone, a dying smoker, in 1983. The
Supreme Court accepted the tobacco industry’s defense that federal law requiring warn-
ing labels on product packages had preempted claims under state law that imposed
liability for failure to warn. The United States Supreme Court left open several other
approaches, but the likelihood of recovery seemed small, and counsel for the Cipollone
estate withdrew.
In the third wave, begun soon after the Cipollone decision and still ongoing, diverse
legal arguments have been invoked. This third wave of litigation differs from its prede-
cessors by enlarging the field of plaintiffs, focusing on a range of legal issues, using the
class action device, and making greater attempts to use private law for public policy
purposes. These new claims have been based on theories of intentional misrepresenta-
tion, concealment, and failure to disclose, and such arguments have been joined to a new
emphasis on addiction. For example, in one case that ended as a mistrial, plaintiffs were
barred from presenting evidence that the tobacco companies may have manipulated
nicotine levels. The class action device has figured prominently in these new cases,
which have included claims of smokers as well as claims of those who asserted that they
have been injured by ETS. Arguably the most notable series of third-wave claims brought
against tobacco companies is the proposed 1997 settlement of suits brought by 41 state
attorneys general attempting to recover the states’ Medicaid expenditures for treating
tobacco-related illnesses. In the absence of congressional legislation needed to give that
settlement the force of law, four states made independent settlements with the tobacco
industry. Notably, each state obtained a concession guaranteeing that it would benefit
from any more favorable agreement that another state might later obtain from the
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tobacco industry. Subsequently, a multistate Master Settlement Agreement was negoti-
ated in November 1998 covering the remaining 46 states, the District of Columbia, and
five commonwealths and territories. Another notable recent development is the filing of
large claims by other third-party payers, such as large health care plans.
Perhaps in partial response, the level of litigation initiated by the tobacco industry
itself has increased in recent years and has included a number of well-publicized cases,
including a threatened suit against the media to prevent airing of a program that accused
a tobacco company of manipulating nicotine levels. The company was successful in
making the network withdraw the program, even though similar information was later
made public in other contexts. Although the industry continues aggressive legal pursuit
of its interests on a number of fronts, litigation against the industry has had undoubted
impact on tobacco regulation and is likely to continue to play a key role in efforts to reduce
tobacco use.
Overview and Implications
Tobacco products are far less regulated in the United States than they are in many
other developed countries. This level of regulation applies to the manufactured tobacco
product; to the advertising, promotion, and sales of these products; and to the protection
of nonsmokers from the involuntary exposure to ETS from the use of these products. As
with all other consumer products, adult users of tobacco should be fully informed of the
products’ ingredients and additives and of any known toxicity when used as intended.
Additionally, as with other consumer products, the manufactured tobacco product should
be no more harmful than necessary given available technology. The sale, distribution,
and promotion of tobacco products need to be sufficiently regulated to protect underage
youth from influences to take up smoking. Finally, involuntary exposure to ETS remains
a common public health hazard that is entirely preventable by appropriate regulatory
policies.
Such are the basic, reasonable regulatory issues related to tobacco products. Yet
these issues remain unresolved as the new millennium begins. When consumers pur-
chase a tobacco product, they receive little information regarding the ingredients, addi-
tives, or chemical composition in the product. Although public knowledge about the
potential toxicity of most of these constituents is negligible, findings in this report con-
clude that the warning labels on cigarette packages in this country are weaker and less
conspicuous than in other countries. Further, the popularity of “low tar and nicotine”
brands of cigarettes has shown that consumers may be misled by another, carefully
crafted kind of information—that is, by the implied promise of reduced toxicity underly-
ing the marketing of these products.
Current regulation of the advertising and promotion of tobacco products in this coun-
try is considerably less restrictive than in several other countries, notably Canada and
New Zealand. The review of current case law in this report supports the contention that
greater restrictions of tobacco product advertising and promotion could be legally justi-
fied. In fact, the report concludes that regulation of the sale and promotion of tobacco
products is needed to protect young people from smoking initiation.
ETS contains more than 4,000 chemicals; of these, at least 43 are known carcinogens
(Environmental Protection Agency 1992). Exposure to ETS has serious health effects
(USDHHS 2000b). Despite this documented risk, research has demonstrated that more
than 88 percent of nonsmokers in this country aged 4 years and older had detectable
18 MMWR December 22, 2000
levels of serum cotinine, a marker for exposure to ETS (Pirkle et al. 1996). The research
reviewed in this report indicates that smoking bans are the most effective method for
reducing ETS exposure. Four Healthy People 2010 objectives address this issue and seek
optimal protection of nonsmokers through policies, regulations, and laws requiring smoke-
free environments in all schools, worksites, and public places.
Despite the widespread support among the general public, policymakers, and the
tobacco industry for restricting the access of minors to tobacco products, a high propor-
tion of underage youth smokers across this country continue to be able to purchase their
own tobacco. National efforts by the Substance Abuse and Mental Health Services Ad-
ministration to increase the enforcement of state laws to comply with the Synar Amend-
ment and by the FDA to implement the access restrictions defined in their 1996 rule have
reduced the percentage of retailers in many states who sell to minors. Unfortunately,
nine states failed to attain their Synar Amendment targets in 1999. Additionally, the
March 2000 Supreme Court ruling that the FDA lacks jurisdiction to regulate tobacco
products has suspended all enforcement of the agency’s 1996 regulations. Although
several states have increased emphasis on this issue as part of their state-funded pro-
gram efforts, the loss of the FDA’s program removes a major infrastructure in support of
these state efforts. The current regulatory environment poses considerable challenges
for the interweaving of regulation into a comprehensive, multicomponent approach to
tobacco use control and prevention.
Economic Approaches (Chapter 6)
The argument for using economic policy for reducing tobacco use requires consider-
able technical and analytic understanding of economic theory and data. Because experi-
ments and controlled trials—in the usual sense—are not available to the economist,
judgment and forecasting depend on the results of complex analysis of administrative
and survey data. Such analyses have led to a number of conclusions regarding the
importance of the tobacco industry in the U.S. economy and regarding the role of policies
that might affect the supply of tobacco, affect the demand for tobacco, and use different
forms of taxation as a possible mechanism for reducing tobacco use.
Supply
The tobacco support program has successfully limited the supply of tobacco and
raised the price of tobacco and tobacco products. However, the principal beneficiaries of
this program are not only the farmers whose income is supported but also the owners of
the tobacco allotments. If policies were initiated to ameliorate some short-run effects, the
tobacco support program could be removed without imposing substantial losses for
many tobacco farmers. Eliminating the tobacco support program would lead to a small
reduction in the prices of cigarettes and other tobacco products, which would lead to
slight increases in the use of these products. However, because the support program has
created a strong political constituency that has successfully impeded stronger legislation
to reduce tobacco use, removing the support program could make it easier to enact
stronger policies that would more than offset the impact that the resulting small reduc-
tions in price would have on demand.
Throughout the 1980s and 1990s, competition within the tobacco industry appeared
to have decreased as a result of the favorable deregulatory business climate and an
apparent increase in collusive behavior. This reduction in competition, coupled with the
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addictive nature of cigarette smoking, has magnified the impact that higher cigarette
taxes and stronger smoking reduction policies would have on demand.
The recent expansion of U.S. trade in tobacco and tobacco products through multina-
tional agreements, together with the U.S. threat of retaliatory trade sanctions were other
countries to impede this expansion, is nearly certain to have increased the use of tobacco
products worldwide. Such an increase would result in a consequent global rise in morbid-
ity and mortality related to cigarette smoking and other tobacco use. These international
trade policy efforts conflict with current domestic policies (and the support of compa-
rable international efforts) that aim to reduce the use of tobacco products because of
their harmful effects on health.
Industry Importance
Although employment in the tobacco industry is substantial, the industry greatly
overstates the importance of tobacco to the U.S. economy. Indeed, most regions would
likely benefit—for example, through redistribution of spending and changes in types of
job—from the elimination of revenues derived from tobacco products. Moreover, as the
economies of tobacco-growing regions have become more diversified, the economic
importance of tobacco in these areas has fallen. Higher tobacco taxes and stronger
prevention policies could be joined to other efforts to further ease the transition from
tobacco in major tobacco-producing regions. Finally, trading lives for jobs is an ill-
considered strategy, particularly with the availability of stronger policies for reducing
tobacco use.
Demand
Increases in the price of cigarettes will lead to reductions in both smoking prevalence
and cigarette consumption among smokers; relatively large reductions are likely to oc-
cur among adolescents and young adults. Limited research indicates that increases in
smokeless tobacco prices will similarly reduce the use of these products. More research
is needed to clarify the impact of cigarette and other tobacco prices on the use of these
products in specific sociodemographic groups, particularly adolescents and young adults.
Additional research also is needed to address the potential substitution among ciga-
rettes and other tobacco products as their relative prices change.
Taxation
After the effects of inflation are accounted for, federal and average state excise taxes
on cigarettes are well below their past levels. Similarly, average cigarette excise taxes in
the United States are well below those imposed in most other industrialized countries.
Moreover, U.S. taxes on smokeless tobacco products are well below cigarette taxes.
Studies of the economic costs of smoking report a wide range of estimates for the opti-
mal tax on cigarettes. However, when recent estimates of the costs of ETS (including the
long-term costs of fetal and perinatal exposure to ETS) are considered, and when the
premature death of smokers is not considered an economic benefit, a tax that would
generate sufficient revenues to cover the external costs of smoking is almost certainly
well above current cigarette taxes. The health benefits of higher cigarette taxes are
substantial. By reducing smoking, particularly among youth and young adults, past tax
increases have significantly reduced smoking-related morbidity and mortality. Further
increases in taxes, indexed to account for the effects of inflation, would lead to substan-
tial long-run improvements in health.
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The revenue potential of higher cigarette and other tobacco taxes—obviously not in
itself a goal—is considerable; significant increases in these taxes would lead to sizable
increases in revenues for many years. However, because of the greater price respon-
siveness of adolescents and young adults and the addictive nature of tobacco use, the
long-run increase in revenues is likely to be less than the short-run gain. Nevertheless,
current federal and most state tobacco taxes are well below their long-run revenue-
maximizing levels.
In short, the research reviewed in this report supports the position that raising to-
bacco prices is good public health policy. Further, raising tobacco excise taxes is widely
regarded as one of the most effective tobacco prevention and control strategies. Re-
search indicates that increasing the price of tobacco products would decrease the preva-
lence of tobacco use, particularly among minors and young adults. As noted, however,
this report finds that both the average price of cigarettes and the average cigarette
excise tax in this country are well below those in most other industrialized countries and
that the taxes on smokeless tobacco products are well below those on cigarettes. Making
optimal use of economic strategies in a comprehensive program poses special problems
because of the complexity of government and private controls over tobacco economics
and the need for a concerted, multilevel, political approach.
Comprehensive Programs (Chapter 7)
Community-based interventions were originally developed as research projects that
tested the efficacy of a communitywide approach to risk reduction. A number of national
and international efforts to control cardiovascular disease (in the United States, notably
the Minnesota, Stanford, and Pawtucket studies) used controlled designs. The results
from these and other studies were largely disappointing, particularly regarding preven-
tion and control of tobacco use. Other large-scale research efforts, such as the Commu-
nity Intervention Trial (COMMIT) for Smoking Cessation, also failed to meet their primary
goals for smoking reduction and cessation. Similarly, the results to date from numerous
worksite-based cessation projects suggest either no impact or a small net effect (sum-
marized in Chapter 4).
As these studies were under way in the 1970s and 1980s, health promotion—an
organized approach to changing social, economic, and regulatory  environments—
emerged as a more effective mechanism for population behavior change than traditional
health education. Although the aforementioned community-based research projects used
a health promotion perspective, they lacked the reach and penetration required for
effective social change. In any event, the results made clear the distinction between a
specific program (even one using multiple modalities) and a comprehensive multi-
message, multichannel approach that used some or all of the modalities described in
Chapters 3 through 6.
On a broader scale, other social initiatives can also serve some of these same pur-
poses through means that are not directly related to changing population behavior. For
example, direct advocacy—the presentation of information to decision makers to en-
courage their support for nonsmoking policies—has been pursued vigorously by health
advocates since the organization of grassroots movements for nonsmokers’ rights in the
early 1970s. Much of the clean air legislation now in place may be attributed in part to
such direct advocacy. An interesting observation that supports the logic behind compre-
hensive programs is that initial shortcomings in direct advocacy activity may have been
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related to a failure of coordination among grassroots groups and professional organiza-
tions. In recent years, in part as the result of electronic networking and mediating by the
Advocacy Institute, a more unified approach to reducing tobacco use has been achieved
among the participating organizations.
Media advocacy—the use of mass media to advance public policy initiatives—has
also been effective in placing smoking issues in the public eye and maintaining a contin-
ued impetus for reducing tobacco use. Case analysis of several instances of such activ-
ity— advocacy opposing the promotion of the “X” cigarette, the marketing of “Dakota”
cigarettes, the Philip Morris-sponsored Bill of Rights tour, and the attempted marketing of
“Uptown” cigarettes—highlights several successes but also indicates that such activi-
ties do not always achieve their immediate aims. Nonetheless, considerable experience
has been gained in seizing such opportunities.
Countermarketing activities can promote smoking cessation and decrease the likeli-
hood of initiation. Countermarketing campaigns also can have a powerful influence on
public support for tobacco control activities and provide an educational climate that can
enhance the efficacy of school- and community-based efforts. For youth, the CDC has
estimated that the average 14-year-old has been exposed to more than $20 billion in
imagery advertising and promotions since age 6, creating a “friendly familiarity” for
tobacco products. The recent increase in movie depictions of tobacco use further
enhances the image of tobacco use as glamorous, socially acceptable, and normal. In
light of the ubiquitous and sustained protobacco messages, countermarketing campaigns
need to be of comparable intensity and duration to alter the general social and environ-
mental atmosphere supporting tobacco use.
Perhaps the most important aspect of comprehensive programs has been the emer-
gence of statewide tobacco control efforts as a laboratory for their development and
evaluation. The number of states with such programs grew slowly in the early and mid-
1990s, but in recent years there has been a surge in funding for such efforts fueled by the
state settlements with the tobacco industry. Although the data on the impact of these
programs on per capita consumption, adult prevalence, and youth prevalence are gener-
ally favorable, the uniform data systems needed to conduct more controlled evaluations
of these efforts are still emerging. Nevertheless, the Institute of Medicine (2000) has
concluded that these “multifaceted state tobacco control programs are effective in
reducing tobacco use” (p. 4). The challenge for the new millennium will be to ensure that
these ever-increasing comprehensive statewide tobacco control programs are as effi-
cient and effective as possible.
The review of statewide tobacco control programs indicates that reducing the broad
cultural acceptability of tobacco use necessitates changing many facets of the social
environment. In addition, this report stresses—as does the Best Practices document—
that these individual components must work together to produce   the synergistic effects
of a comprehensive program. However, both of these findings highlight the complexity
involved in evaluating these types of programs.
Within the current statewide tobacco control programs, each of these various mo-
dalities discussed in this report is represented with varying degrees of intensity. As
noted above, some of the recommendations for actions within these
modalities could most effectively be done at the national rather than the state level.
Thus, the overall efficacy of these emerging statewide programs will depend in some
ways on public health advances at the national level. Again, this synergy between the
statewide and national efforts adds greater complexity to the evaluation issue.
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Finally, this report concludes that the span of impact of these educational, clinical,
regulatory, economic, and social approaches indicates the importance of their sustained
and long-term implementation. Program evaluation and research efforts are needed to
improve our understanding of how these various elements work. Although knowledge
about the efficacy of comprehensive programs is imperfect, evidence points to early
optimism for their continuance. With the expansion of tobacco control surveillance and
evaluation systems and increases in the number and diversity of statewide tobacco
control programs, critical questions can be answered about how to make these efforts
more efficient and effective.
A Vision for the Future—Reducing Tobacco Use
in the New Millennium (Chapter 8)
In its assessment of the trajectory of tobacco control activities in the coming years,
the report focuses on six future challenges: the scientific base, the changing tobacco
industry, the need for comprehensive approaches, identifying and eliminating dispari-
ties, improving dissemination of interventions, and influencing tobacco use in developing
nations.
Continuing to Build the Scientific Base
Beginning with the 1964 Surgeon General’s report, Smoking and Health, tobacco
control policy in this nation has been built on a foundation of scientific knowledge. Each of
the subsequent 24 reports of the Surgeon General on tobacco use has documented a
vast and growing body of scientific literature. The substantial research reviewed in this
report focuses on a key segment of the literature—what has been tried in the decades-
old effort to reduce tobacco use. In turn, this focus clarifies which efforts work best.
Certainly more research is needed so that these efforts can be more efficient and effec-
tive; the key conclusion from this report, however, is that we know more than enough to
take actions now to decrease the future health burden of tobacco-related disease and
death in this country.
In the process of applying our current state of knowledge about preventing and con-
trolling tobacco use, accountability and evaluation of the public health effort will be
critical. However, because of the wide array of educational, clinical, regulatory, eco-
nomic, and social influences that have and will need to be brought to bear on the tobacco
use problem, the direct impact of a specific maneuver on a specific outcome becomes
less meaningful as the combined effects become more substantial. Investigators tend to
work on small, manageable aspects of the tobacco use problem, but the synergistic
influence of multiple factors over time will likely extend far beyond the outcomes pre-
dicted from these smaller research undertakings. For example, as this report demon-
strates, the most efficacious educational programs are those that take place in a larger
community context, one that engenders and supports an environment of nonsmoking.
Similarly, although clinical interventions to manage tobacco addiction clearly have some
specific power to help smokers quit, primarily through pharmacologic means, the social
environment remains a major determinant of whether these new former smokers main-
tain their abstinence from nicotine addiction. Regulatory efforts, on the other hand, raise
a host of social and economic issues and can produce broad societal changes—issues
and changes, however, that are difficult to isolate, document, and evaluate. Economic
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strategies also have a great potential, but being fundamentally political in nature, they
require public consensus and changes in social norms before they can be attempted.
Finally, the public health advocacy involved in social program modalities is virtually
impossible to assess in a prospective or controlled research design.
The research and evaluation tools of public health must expand to meet these com-
plex issues. Comprehensive, multifactorial approaches to tobacco control appear to of-
fer the most promise. However, the penalty for comprehensive approaches is a loss of
statistical power to attribute outcomes to specific activities. Within each of the modalities,
appropriate evaluation methodologies are being used. However, many of these method-
ologies involve retrospective case study, time trend, econometric, and surveillance ap-
proaches to evaluate the “natural experiment” as it evolves in the changing social
environment. Thus, the traditional biomedical and epidemiologic research methods that
have worked so well in defining the health consequences of tobacco use are not well
suited to evaluate the potentially most efficacious methods to reduce tobacco use.
The Changing Tobacco Industry
This report documents that this country’s efforts to prevent the onset or continuance
of tobacco use have faced the pervasive, countervailing influences of tobacco promotion
by the tobacco industry. Despite the overwhelming and continually growing body of
evidence of adverse health consequences of tobacco use, the norm of social acceptance
of tobacco use in this nation has receded more slowly than might be expected, in part
because of such continued promotion.
Litigation and legal settlements have produced notable changes in the
tobacco industry’s public positions on health risks, nicotine addiction, and advertising and
promotion limits. Additionally, individual manufacturing companies have become more
directly involved in efforts to limit the access of underage persons to tobacco products
and to prevent young people from initiating tobacco use. In this rapidly changing social
and legal environment, it is difficult to project the nature and scope of future changes by
the industry or their impact on the national effort to reduce tobacco use. Nevertheless,
any analysis of changes in patterns of tobacco use must consider the influence of these
industry changes.
One of the major arenas of potential change will be in the tobacco product itself. The
manufactured cigarette that is widely marketed in the developed world was noted to be
changing dramatically when this issue was first considered by the Surgeon General in
1981, The Changing Cigarette (USDHHS 1981). Recent public statements by the to-
bacco industry suggest that the pace of changes in the manufactured cigarette could be
accelerating in the future. The public health implications of changes in manufactured
cigarettes and other tobacco-containing products will require careful and significant
attention from both public health researchers and policymakers.
The litigation environment has demonstrated the importance of tobacco industry
documents in analyzing the industry’s influence. Legal and public health analyses are just
beginning to sift through the millions of pages of documents made public as part of the
various legal actions undertaken over the last decade. As this process continues, public
health researchers may develop better methods to define and evaluate the industry’s
past activities that may have contributed to the character, pace, or direction of changes
in tobacco use patterns in this country or around the world.
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The Need for Comprehensive Approaches
The evidence of effectiveness summarized in this report emphasizes that public health
success in reducing tobacco use requires activity using multiple modalities. A compre-
hensive approach—one that optimizes synergy from applying a mix of educational, clini-
cal, regulatory, economic, and social strategies—has emerged as the guiding principle
for future efforts to reduce tobacco use. The public health goals of such comprehensive
programs are to reduce disease, disability, and death related to tobacco use through
prevention and cessation, as well as through protection of the nonsmoker from ETS.
The emerging body of data on statewide tobacco control efforts is coming from pro-
grams broadly focused on prevention, cessation, and protection of the nonsmoker from
ETS (Chapter 7). Preventing initiation among young people is a primary goal of any
tobacco control effort. However, young people will perceive contradictory or inconsis-
tent messages in our prevention efforts if programs do not also address the smoking
behavior of millions of parents and other adult role models and the public health risks of
ETS.
CDC recently released Best Practices for Comprehensive Tobacco Control Programs
(CDC 1999), which recommends that states establish tobacco control  programs that are
comprehensive, sustainable, and accountable. This document draws on “best practices”
determined by evidence-based conclusions from research and evaluation of such com-
prehensive programs at the state level. In the review of evidence from these states, it
was evident that reducing the broad cultural acceptability of tobacco use necessitates
changing many facets of the social environment. Nine specific elements of a comprehen-
sive program are defined in the guidance document. Although the importance of each of
the elements is highlighted, the document stresses that these individual components
must work together to produce the synergistic effects of a comprehensive program.
Best Practices thus provides effective guidance for state-level efforts; a comprehen-
sive national tobacco control effort, however, requires strategies that go beyond this
guidance to states. Moreover, a comprehensive national effort should involve the appli-
cation of a mix of educational, clinical, regulatory, economic, and social strategies. In each
of these modalities, some of the program and policy changes that are needed can be
addressed most effectively at the national level.
Identifying and Eliminating Disparities
The elimination of health disparities related to tobacco use poses a great national
challenge. Although this issue was not a major aspect of the current report, two other
recent USDHHS publications have taken this focus. The 1998 Surgeon General’s report
Tobacco Use Among U.S. Racial/Ethnic Minority Groups  was the first to address the
diverse tobacco control needs of the four major U.S. racial/ethnic minority groups—
African Americans, American Indians and Alaska Natives, Asian Americans and Pacific
Islanders, and Hispanics (USDHHS 1998). Similarly, Healthy People 2010, released in
January 2000, has two overarching goals: increase quality and years of healthy life and
eliminate health disparities among different segments of the U.S. population (USDHHS
2000a). Both publications not only highlight the significant disparities in health that exist
in the United States but also stress the critical need for a greater focus on this issue, both
in research and in public health action.
Cultural, ethnic, religious, and social differences are clearly important in under-
standing patterns of tobacco use, but little research has been completed on the relative
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effectiveness of interventions for prevention and treatment in some of the population
groups or communities. Reaching the national goal of eliminating health disparities
related to tobacco use will necessitate improved collection and use of standardized data
to correctly identify disparities in both health outcomes and efficacy of prevention pro-
grams among various population groups. Broader historical, societal, and community
characteristics can have a significant influence on the manner in which prevention and
control strategies that work overall for the population as a whole may impact diverse
groups. Many of these broader variables do not lend themselves to traditional measure-
ment methods nor are they easily assessed at the individual level through using tradi-
tional epidemiologic methods.
Improving the Dissemination of State-of-the-Art Interventions
One of the greatest challenges in tobacco control and public health in general contin-
ues to be overcoming the difficulty in getting advances in prevention and treatment
strategies effectively disseminated, adopted, and implemented in their appropriate de-
livery systems. Simply stated, our recent lack of progress in tobacco control is attribut-
able more to the failure to implement proven strategies than it is to a lack of knowledge
about what to do. The result is that each year in this nation, more than 1 million young
people continue to become regular smokers, and more than 400,000 adults continue to
die prematurely from tobacco-related diseases.
Within each of the modalities reviewed in this report, some specific research ad-
vances in tobacco prevention and control strategies have not been fully implemented.
Studies are urgently needed to identify the social, institutional, and political barriers to
the more rapid dissemination of these research advances. Understanding these barriers
and determining how they could be overcome would benefit not only tobacco control but
public health efforts more broadly.
Tobacco Use in Developing Nations
Analyses by the World Health Organization (WHO) have concluded that by 2030,
current smoking patterns will produce about 500 million premature deaths from tobacco-
related disease among people alive today (WHO 1999). WHO further estimates that by
2030, tobacco is expected to be the single greatest cause of death worldwide, accounting
for an estimated 10 million deaths per year. Although the impact of tobacco-related
disease and death has been until recently a problem primarily for the developed coun-
tries of this world, WHO now estimates that by 2020, 7 of every 10 tobacco-related
deaths will be in the developing world.
This report addresses research on strategies to reduce tobacco use within our nation’s
social, legal, and cultural environments. Nevertheless, findings from this report may
have broad utility in the planning of tobacco control efforts around the world. As Chapter
2 documents, the public health response in this country to the scientific findings about the
health consequences of tobacco products has taken more than four decades to emerge.
In many parts of the developing world, the problems of tobacco use are similar to those
in this country in the 1950s and 1960s. Hence, a key public health question for this
millennium may be the following: can the time interval be significantly shortened be-
tween when the health risks of tobacco for a developing country are recognized and
when a comprehensive national response is begun?
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WHO, the World Bank, and the United Nations Foundation, with technical assistance
from the CDC, have undertaken major new initiatives to address this problem. The WHO
Tobacco Free Initiative is developing an international tobacco control infrastructure, which
includes a global tobacco surveillance system, intervention tool kits, and regional techni-
cal assistance workshops. The World Bank has published Curbing the Epidemic: Govern-
ments and the Economics of Tobacco Control (Jha and Chaloupka 1999). This document
provides an economic analysis that supports a multipronged approach to tobacco con-
trol, involving raising excise taxes, promoting policy changes related to the sales and
promotion of tobacco products as well as to restrictions on smoking in public places, and
widening access to smoking cessation therapies. The scientific findings in this report are
consistent with the programmatic recommendations of both the WHO Tobacco Free
Initiative and the World Bank document.
A momentous undertaking of WHO and member states, including the United States,
is the development and negotiation of the Framework Convention on Tobacco Control. If
brought to its intended ratification in the next few years, this agreement would provide a
framework within which countries could develop more specific bilateral and multilateral
protocols for cooperation on containing the spread of the tobacco epidemic. The frame-
work would enable countries to start from a common understanding of the issues, priori-
ties, and strategies necessary to harmonize tobacco control efforts among themselves
so that some countries do not benefit at the expense of others. This is the spirit of the
other activities of U.S. governmental and nongovernmental agencies in their effort to
collaborate with WHO and with other countries in their development of surveillance,
cessation, prevention, mass media, regulatory, economic, and social approaches to glo-
bal tobacco control.
In the near future, emphasis must be placed on the development of surveillance
systems so that countries can know the extent, distribution, and trends of the tobacco
consumption problems in their populations. These systems will also track—for interna-
tional comparison and monitoring of progress—the emergence of new forms of tobacco
promotion, as well as new legislation, regulations, and programs for countering tobacco
use. In the longer term, the gaps must be filled in each country’s defenses against the
incursions of tobacco use on their young people and other vulnerable populations. In
particular, there will be a continuing need to ensure that the rapidly expanding knowl-
edge about the efficacy of various tobacco control modalities be made available to the
developing world.
The challenge to the world is to prevent tobacco use, particularly smoking, from ever
becoming the leading cause of preventable illness and death in the world. Dr. Gro Harlem
Brundtland, the current director-general of WHO, clearly defined this challenge when
she stated, “If we do not act decisively, a hundred years from now our grandchildren and
their children will look back and seriously question how people claiming to be committed
to public health and social justice allowed the tobacco epidemic to unfold unchecked”
(Asma et al., in press).
TOBACCO CONTROL IN THE NEW MILLENNIUM
Tobacco use will remain the leading cause of preventable illness and death in this
nation and a growing number of other countries until tobacco prevention and control
efforts are commensurate with the harm caused by tobacco use. This report provides the
composite review of the major methods—educational, clinical, regulatory, economic,
and social—that can guide the development of this expanded national effort. This report
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is, therefore, a prologue to the development of a coherent, long-term tobacco policy for
this nation.
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